ReviewFrontiers in immunology2026
Targeting the remodeled peritoneal ecosystem: a paradigm shift from tumor cells to the microenvironment in gastric cancer peritoneal metastasis.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peritoneal metastasis (PM) is the most common form of organ-specific metastasis in advanced gastric cancer (GC), and is driven by the dynamic interplay between cancer cells and the tumor microenvironment (TME). This review elaborates on the mechanisms through which cancer cells utilize metabolic reprogramming, mechanical stress, and neural control to shape the microenvironment conducive to tumor growth. It also describes the metastatic cascade of their active dissemination and colonization processes of cancer cells within the peritoneal cavity. Finally, on the basis of these mechanistic insights, we propose a three-step strategy that dismantle physical barriers, blocks nutrient supply, and reverses immune suppression. The aim of this study to transform PM from a treatment challenge into a manageable disease, further improving disease prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.